市場調査レポート
商品コード
1073947
経カテーテル心臓弁置換の世界市場規模:タイプ(経カテーテル大動脈弁置換、経カテーテル僧帽弁修復)・外科的アプローチ・エンドユーザー・地域別の予測(2022年~2028年)Global Transcatheter Heart Valve ReplacementMarket Size study, by Type (Transcatheter aortic valve replacement, Transcatheter mitral valve repair ), by Surgical Approach, by End-User and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
経カテーテル心臓弁置換の世界市場規模:タイプ(経カテーテル大動脈弁置換、経カテーテル僧帽弁修復)・外科的アプローチ・エンドユーザー・地域別の予測(2022年~2028年) |
出版日: 2022年05月06日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の経カテーテル心臓弁置換の市場規模は、予測期間である2022年~2028年には12%以上の健全な成長率で拡大すると予測されています。
低侵襲手術、回復時間の短縮、生存率の向上、心臓弁膜症患者の増加に対する需要の拡大が、予測期間にわたって経カテーテル心臓弁置換の採用を促進しています。また、外科手術の進歩、メーカーの関心と市場シェアの増加は、経カテーテル心臓弁置換市場の全体的な成長を後押しする可能性が高いです。
しかし、弁の交換とその滑りに関連するリスクや、血管が裂ける高いリスクは、2022年~2028年の予測期間にわたり、市場の拡大を妨げる可能性があります。
当レポートでは、世界の経カテーテル心臓弁置換市場を調査し、市場の概要、業界分析、COVID-19によるリスク評価、タイプ・外科的アプローチ・エンドユーザー・地域別の分析、および競合情報などを提供しています。
List of figures
Global Transcatheter Heart Valve Replacement Market is valued at approximately USD xyz billion in 2021 and is anticipated to grow with a healthy growth rate of more than 12% over the forecast period 2021-2027. Transcatheter heart valve replacement is a minimally invasive cardiac operation that replaces a thickened heart valve (Aortic or Mitral) that can no longer fully open. Aortic or mitral valve stenosis can be treated with transcatheter heart valve replacement. When the heart's valves thicken and become rigid, it's called aortic or mitral valve stenosis (calcifies). As a result, the valve is unable to fully open, limiting blood flow to the body.Increasing demand for minimally invasive procedures, reduced recovery time, higher survival rates and rising number of patients with vulvar heart disease have driven the adoption of Transcatheter Heart Valve Replacement across the projected period. For Instance: More than 5% of the global population over the age of 65 is at risk of developing valvular heart disease, with 50% of heart patients dying if their heart valve is not replaced or repaired. Also, rising advancements in surgical procedures, rising manufacturers' interests and rising market share are most likely to boost the overall growth of the Transcatheter Heart Valve Replacement market. However, risk associated with the replacement of valve and its slipping and high risk of Blood Vessel Tearing can obstruct the market's expansion over the projection period of 2021-2027
The key regions considered for the global Transcatheter Heart Valve Replacement market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world. Presence of major key players and rising technological advancements is driving the market growth in Europe. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027. The market is expected to grow during the projected period, due to rising disposable income of consumers.
Major market players included in this report are:
Edwards Lifesciences Corporation
Medtronic Inc.
Boston Scientific Corporation
Abbott Laboratories
St. Jude Medical, Inc.
Jena Valve Technology
SYMETIS
Braile Biomedica
J C Medical
4C Medical Technologies
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Transcatheter aortic valve replacement (TAVR)
Transcatheter mitral valve repair (TMVR)
By Surgical Approach:
Transfemoral approach
Transapical approach
Transaortic approach
By End-User:
Hospitals
Ambulatory surgical centres
Cardiac catheterization laboratories
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Transcatheter Heart Valve Replacement Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
11.1 Research Process
11.2 Research Attributes
11.3 Research Assumption